HyBryte™ Treatment Studies Presented at Two Medical Conferences in March
Go back to HyBryte™ Treatment Studies Presented at Two Medical Conferences in March| Soligenix, Inc. (NASDAQ: SNGX) | Delayed: 0.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $4.35 | |||
| Open | $0.38 | 52 Week Low | $0.44 | |||
| Day High | $0.39 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $-0.81 | |||
| Volume | 139,807 | |||||
